Inicio › Cáncer de vejiga › Ohio

Ensayos clínicos de Cáncer de vejiga en Ohio

36 estudios sobre Cáncer de vejiga buscan participantes en Ohio.

Ciudades en Ohio

Texto oficial del estudio (inglés)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Strecker Cancer Center-Belpre, Belpre
Adena Regional Medical Center, Chillicothe
Ohio State University Comprehensive Cancer Center, Columbus
y 22 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT03866382

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
MetroHealth Medical Center, Cleveland
University of Cincinnati Cancer Center-West Chester, West Chester

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07061964

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

TriState Urologic Services PSC Inc. dba The Urology Group ( Site 0122), Cincinnati

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06833073

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

University Hospitals Cleveland Medical Center, Cleveland
Cleveland Clinic Foundation, Cleveland
Cleveland Clinic Taussig Cancer Center Investigational Pharmacy, Cleveland

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07421700

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Riverside Methodist Hospital, Columbus
Grant Medical Center, Columbus
Doctors Hospital, Columbus
y 3 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06770582

DESTINY-PANTUMOUR04

Research Site, Canton
Research Site, Maumee

ReclutandoEstudio observacional

Edades de 18 a 130 · Todos los sexos · Actualizado el 25 sept 2026 · NCT07124000

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0822), Cincinnati

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07419295

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

University of Cincinnati Medical Center, Cincinnati
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07218380

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Ohio State University, Columbus

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT06529822

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

University Hospitals Cleveland Medical Center, Cleveland

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT07217171

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Cleveland Clinic, Cleveland
Toledo Clinic Cancer Center, Toledo

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 sept 2026 · NCT05059444

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

Oncology Hematology Care Clinical Trials, LLC, Fairfield

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT07566156

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

University Hospitals Cleveland Medical Center, Cleveland

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06465069

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

The Urology Group (Solaris), Cincinnati
University of Cincinnati Cancer Center, Cincinnati
Cleveland Clinic, Cleveland
y 2 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06567743

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Cleveland Clinic - Oncology Department, Cleveland

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2026 · NCT06760819

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Summa Health System - Akron Campus, Akron
Cleveland Clinic Akron General, Akron
Summa Health System - Barberton Campus, Barberton
y 44 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT05334069

The Vanguard Study: Testing a New Way to Screen for Cancer

Louis Stokes Cleveland VA Medical Center, Cleveland

ReclutandoSe aceptan voluntarios sanos

Edades de 45 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT06995898

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

Cleveland Clinic Taussig Cancer ( Site 5036), Cleveland

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07232602

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Cleveland Clinic Main Campus, Cleveland, Cleveland

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 ago 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

University of Cincinnati Medical Center (UCMC), Cincinnati
The Ohio State University (OSU), Columbus

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT05614739

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

UH Seidman Cancer Center at UH Avon Health Center, Avon
UHHS-Chagrin Highlands Medical Center, Beachwood
Case Western Reserve University, Cleveland
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 ago 2026 · NCT07097142

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

The Ohio State University Comprehensive Cancer Center, Columbus

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 ago 2026 · NCT05592626

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

University of Cincinnati Medical Center, Cincinnati
Central Ohio Urology Group, Gahanna
Clinical Research Solutions - Helios Clinical Research, Middleburg Heights

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT04752722

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

Ohio State University Comprehensive Cancer Center, Columbus

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07000084

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

The Ohio State University, Columbus

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 31 jul 2026 · NCT07225127

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

Fairview Hospital, Cleveland
Cleveland Clinic, Cleveland
The James Outpatient Care West Campus, Columbus
y 1 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jul 2026 · NCT07106762

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Nationwide Children's Hospital, Colombus
The Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Taylor Cancer Research Center, Maumee

ReclutandoFase 2

Edades de 8 en adelante · Todos los sexos · Actualizado el 27 jul 2026 · NCT05503797

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

University Hospitals Cleveland Medical Center, Cleveland
Ohio State University Hospital, Columbus
Ohio State University, Columbus
y 3 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT04879329

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

Research Site, Cleveland

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT07720284

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Dayton Physicians Network, Dayton

Reclutando

Edades de 18 a 88 · Todos los sexos · Actualizado el 2 jul 2026 · NCT06394869

Integrated Cancer Repository for Cancer Research

Aultman Alliance Community Hospital, Alliance
Aultman Hospital, Canton

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 19 a 110 · Todos los sexos · Actualizado el 29 jun 2026 · NCT02012699

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

Cleveland Clinic, Cleveland
Taylor Cancer Research Center, Maumee

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 feb 2026 · NCT07030257

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Cleveland Clinic, Cleveland

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 en adelante · Todos los sexos · Actualizado el 20 ene 2026 · NCT05366881

Blue Light Cystoscopy With Cysview® Registry

Ohio State University Wexner Medical Center, Columbus
Ohio State University, Columbus

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 18 dic 2025 · NCT02660645

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Cleveland Clinic Taussig Cancer Center, Cleveland
Ohio State University Comprehensive Cancer Center, Columbus

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 dic 2025 · NCT06263153

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Cincinnati
Massive Bio SYNERGY-AI site, Columbus
Massive Bio SYNERGY-AI site, Mayfield Heights

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.